No takes yet. Share an insight, caveat, or question.
This review highlights how lncRNAs affect cancer progression in cells, suggesting they are actionable therapeutic targets for resistance.
Eleonora Leucci (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: